ABCB5 and recessive dystrophic epidermolysis bullosa: Very recently we found that three intravenous infusions of allogeneic skin-derived ABCB5+ MSCs to patients with RDEB decreased disease activity, alleviated itch and pain, and facilitated the healing of the wounds that were present at baseline [19,20].